Chris is a former medtech CEO with 30 years of experience leading new medical products from concept through to market adoption in both venture funded and Fortune 500 companies. Currently Executive Chairman of Global Access Health Ltd, and Non-Executive Director for AIM listed Deltex Medical, MediSieve Ltd, Causeway Therapeutics and Health Enterprise East, Mr Jones is a US national who came to the UK in 2008 to become CEO of GlySure where he led the development of the world’s first continuous intravascular glucose sensor from proof of concept to CE approval.

In his current roles, in addition to strategic direction, fundraising and partnership development, Mr Jones provides hands on support for business-critical areas that are often under-resourced in early stage companies including IP strategy, market assessment, contract negotiation and commercialisation planning.